Displaying drugs 12551 - 12575 of 14436 in total
ONCOS‐102
Investigational
L-Leucyl-L-prolyl-L-prolyl-L-seryl-L-arginine
Investigational
Ad-RTS-hIL-12
Investigational
Tasadenoturev
Investigational
Ad-ISF35
Investigational
Ad-SGE-REIC
Investigational
Alnuctamab
Investigational
ET140203
Investigational
APVO-436
Investigational
Urabrelimab
Investigational
XMMME-001-DTPA 111 Indium
Investigational
APC8020
Investigational
Vadacabtagene leraleucel
Investigational
Anti-CD5 CAR T-cell therapy
Investigational
Anti-CD4 CAR T-cell therapy
Investigational
Gebasaxturev
Investigational
MV-NB-02
Investigational
TPIV 200
TPIV 200 is a vaccine consisting of proteins from the folate receptor alpha mixed with Granulocyte-macrophage colony-stimulating factor (GM-CSF).
Investigational
Onamelatucel-L
Investigational
Falimarev
Investigational
Indium In-111 altumomab pentetate
Investigational
MGN-4893
MGN-4893 is an inhibitor of microRNA-451. In February 2011, it was granted FDA orphan designation for the treatment of polycythemia vera.
Investigational
TNT-1
Investigational
WT-1 122 long
Investigational
SynKIR-110
SynKIR-110 are autologous T cells genetically engineered to express an anti-mesothelin killer immunoglobulin-like receptor-chimeric antigen receptor (KIR-CAR).
Investigational
Displaying drugs 12551 - 12575 of 14436 in total